Skyepharma Competitors and Similar CompaniesClear all

Societal CDMO's competitors and similar companies include Array BioPharma, Amicus Therapeutics and Tricida.
Societal CDMO
Societal CDMO
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
Array BioPharma
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Tricida
Tricida
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Founding Date
Founding Date
2006
Founding Date
1998
Founding Date
2002
Founding Date
2013
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Gainesville, US HQ
Gainesville, US
San Diego, US
Locations
Boulder, US HQ
Chicago, US
Detroit, US
Houston, US
Miami, US
New York, US
Phoenix, US
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Locations
South San Francisco, US HQ
Employees
Employees
21316% decrease
Employees
29843% increase
Employees
58415% increase
Employees
11914% increase
Valuation ($)
Valuation ($)
51.8 m
Valuation ($)
N/A
Valuation ($)
3.9 b
Valuation ($)
N/A
Employee Rating
Employee Rating
3.4
Employee Rating
3.5
Employee Rating
2.9
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
$90.2m (FY, 2022)
Revenue (est.)
$173.8m (FY, 2018)
Revenue (est.)
$329.2m (FY, 2022)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$67.1m (FY, 2022)
Cost of goods
$59.4m (FY, 2018)
Cost of goods
$38.6m (FY, 2022)
Cost of goods
N/A
Gross profit
Gross profit
$23.1m (FY, 2022)
Gross profit
$114.4m (FY, 2018)
Gross profit
$290.6m (FY, 2022)
Gross profit
N/A
Net income
Net income
($19.9m) (FY, 2022)
Net income
($147.7m) (FY, 2018)
Net income
($236.6m) (FY, 2022)
Net income
($176.6m) (FY, 2021)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 88m
Total funding raised
$ 157m
For sources of this data, please see the company profile

View Company Profiles

Array BioPharma
HQ
Boulder, US

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

View company
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company
Tricida
HQ
South San Francisco, US
Employees
119↑ 14% increase

Tricida operates in the healthcare industry focusing on pharmaceutical business.

View company